Table 4.
Hypothetical Outcomes of Thyroid Cancer Evaluation in Model of Obese Patients
| Strategy | Average cost per patient | Incremental cost (% incremental cost) |
|---|---|---|
| No screening | $210.73 | — |
| Universal US screening | $434.10 | +$223.37 (106%) |
| Risk-based screening | $166.72 | −$44.01 (−21%) |